Gyeonggi-do, South Korea

Chungyong Han


Average Co-Inventor Count = 9.0

ph-index = 2

Forward Citations = 16(Granted Patents)


Location History:

  • Gyeonggi-do, KR (2018 - 2019)
  • Seoul, KR (2022)

Company Filing History:


Years Active: 2018-2022

where 'Filed Patents' based on already Granted Patents

3 patents (USPTO):

Title: Innovations of Chungyong Han in B Cell Lymphoma Treatment

Introduction

Chungyong Han is a notable inventor based in Gyeonggi-do, South Korea. He has made significant contributions to the field of medical science, particularly in the development of treatments for B cell lymphoma. With a total of three patents to his name, Han's work is paving the way for advancements in cancer therapy.

Latest Patents

One of Han's latest patents involves a monoclonal antibody that specifically recognizes B cell lymphoma cells. This invention includes a pharmaceutical composition aimed at preventing or treating B cell lymphoma, as well as a diagnostic composition that utilizes the monoclonal antibody. Additionally, the patent outlines a method for providing diagnostic information using the antibody, a chimeric antigen receptor (CAR) protein, and a recombinant vector that expresses the CAR protein. Furthermore, it describes CAR-modified T cells transformed with the recombinant vector, along with a pharmaceutical composition for treating B cell lymphoma that includes these CAR-modified T cells. The patent also covers an antibody-drug conjugate that combines the monoclonal antibody with a drug.

Career Highlights

Chungyong Han is currently associated with Eutilex Co., Ltd., where he continues to innovate in the field of biotechnology. His work is instrumental in developing new therapeutic strategies for cancer treatment, particularly focusing on B cell lymphoma.

Collaborations

Han collaborates with esteemed colleagues such as Byoung S Kwon and Kwang-Hui Kim, contributing to a dynamic research environment that fosters innovation and discovery.

Conclusion

Chungyong Han's contributions to the field of cancer treatment through his innovative patents highlight his role as a leading inventor in biotechnology. His work not only advances scientific knowledge but also holds the potential to improve patient outcomes in the fight against B cell lymphoma.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…